2 unknown, 2 withdrawn, 1 completed, 1 not yet recruiting. 7 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Unknown 2, Withdrawn 2, Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 5 | Unknown 2, Completed 1, Not yet recruiting 1, Recruiting 1 |
Follow Corneal Disease: new trials by email Literature Review of Corneal Disease trials Research Report on Corneal Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone - Multiple Myeloma, Neoplasms | Phase 1 / Phase 2 | Recruiting | Hellenic Society of Hematology | 36 | 2023-07-14 | 2023-10-24 |
| NGF Treatment for Patients With Neuropathic Corneal Pain Cenegermin-Bkbj - Corneal Disease, Neuropathy | Phase 1 | Withdrawn | Tufts Medical Center | 2022-11-01 | 2023-01-26 | |
| A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide - Multiple Myeloma, Multiple Myeloma in Relapse | Phase 1 / Phase 2 | Not yet recruiting | Hellenic Society of Hematology | 48 | 2022-10-20 | 2022-10-17 |
| A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible Belantamab Mafodotin-Blmf, Daratumumab, Lenalidomide - Multiple Myeloma, Neoplasms | Phase 1 / Phase 2 | Unknown | Hellenic Society of Hematology | 36 | 2022-04-13 | 2023-12-01 |
| Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells mesenchymal stem cells, limbal stem cells, standard treatment - Corneal Ulcer, Corneal Disease | Phase 1 / Phase 2 | Completed | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 25 | 2016-10-03 | 2020-07-30 |
| Evaluation of Biosynthetic Constructs to Replace Donor Corneas NuCornea, donated human corneas - Corneal Disease | Phase 1 | Withdrawn | Region Östergötland | 2015-06-01 | 2016-04-15 | |
| Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation LSCs and amniotic membrane (Modified Technique), Amniotic membrane only (Traditional Technique), PRK, LSCs, and amniotic membrane (Modified Technique) - Corneal Disease, Pterygium | Phase 1 / Phase 2 | Unknown | Sun Yat-sen University | 30 | 2012-12-01 | 2014-05-28 |
Corneal Diseases (7) · Blood Protein Disorders (3) · Hematologic Diseases (3) · Multiple Myeloma (3) · Neoplasms (3) · Neoplasms, Plasma Cell (3) · Paraproteinemias (3) · Corneal Dystrophies, Hereditary (1) · Corneal Ulcer (1) · Hyperopia (1) · Myopia (1) · Pterygium (1) · Refractive Errors (1)
Eye Diseases (7) · Cardiovascular Diseases (3) · Hemic and Lymphatic Diseases (3) · Hemorrhagic Disorders (3) · Hemostatic Disorders (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphoproliferative Disorders (3) · Neoplasms by Histologic Type (3) · Vascular Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Conjunctival Diseases (1) · Eye Diseases, Hereditary (1) · Eye Infections (1) · Genetic Diseases, Inborn (1)
Dexamethasone (3) · Lenalidomide (2) · daratumumab (2) · Betamethasone (1) · Levofloxacin (1) · cenegermin (1) · nirogacestat (1) · pomalidomide (1)
Hellenic Society of Hematology (3) · Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1) · Region Östergötland (1) · Sun Yat-sen University (1) · Tufts Medical Center (1)
Greece (2) · Belarus (1) · China (1) · United States (1)
Evangelos Terpos, Prof (3) · Igor Volotovski, Prof (1) · Liudmila Marchenko, Prof (1) · Pedram Hamrah, MD (1) · Per Fagerholm, MD,PhD (1) · Yizhi Liu, MD, PhD (1) · Zinaida Kvacheva (1)